| Mrs Carol Lynn Herzberg, APNP | |
|
S89w23120 King Pkwy, Big Bend, WI 53103-9720 | |
| (262) 662-4824 | |
| Not Available |
| Full Name | Mrs Carol Lynn Herzberg |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | S89w23120 King Pkwy, Big Bend, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871743138 | NPI | - | NPPES |
| 39734300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 399-033 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Carol Lynn Herzberg, APNP S89w23120 King Pkwy, Big Bend, WI 53103-9720 Ph: (262) 662-4824 | Mrs Carol Lynn Herzberg, APNP S89w23120 King Pkwy, Big Bend, WI 53103-9720 Ph: (262) 662-4824 |
News Archive
A team of experts from around Europe has come together to develop a portable device with a hand-held probe that will dramatically reduce invasive diagnostic and therapeutic procedures in the treatment of thyroid nodules, saving approximately €450 million Euros every year.
While every one of our cells contains all of our genetic information, each type of cell uses only specific parts of that information to make its proteins. Uncovering more about the mechanism that directs which particular pieces of genetic information the cell uses is the research focus of Mary Ann Osley, PhD, University of New Mexico Professor of Molecular Genetics and Microbiology and Co-Leader of the Cancer Biology and Biotechnology Program at the UNM Cancer Center.
Fashion trends and concerns about appearance could be having a detrimental effect on the health and fitness of our nation's women according to a new survey commissioned by Cancer Research UK's Race for Life, in partnership with Tesco.
A new approach to killing C. difficile that silences key bacterial genes while sparing other bacteria may provide a new way to treat the most common hospital-acquired bacterial infection in the United States, according to researchers.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
› Verified 1 days ago